About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

359,057 studies
in
219 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/22/2021.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/22/2021.

Lumen-apposing Metal Stent With or Without Coaxial Plastic Stent for Treatment of Walled-off Pancreatic Necrosis

Clinicaltrials.gov identifier NCT03923686

Recruitment Status Recruiting

First Posted April 22, 2019

Last update posted April 2, 2020

Study Description

Brief summary:

A prospective randomized cohort study to compare whether the placement of a double-pigtail plastic stent (DPS) within a lumen-apposing metal stent (LAMS) may improve the efficacy and safety of endoscopic ultrasound guided transmural drainage of walled-off pancreatic necrosis (WON) and thus prevent potential adverse events related to LAMS insertion.

  • Condition or Disease:Pancreatitis, Acute Necrotizing
    Walled Off Necrosis
  • Intervention/Treatment: Procedure: EUS-guided drainage using LAMS with DPS
    Procedure: EUS-guided drainage using LAMS alone
  • Phase: N/A
Detailed Description

The aim of the study is to compare endoscopic ultrasound guided transmural drainage using lumen-apposing metal stent with (1.) or without (2.) coaxial plastic stent in the management of walled-off pancreatic necrosis. The usage of LAMS has been evaluated as a safe and effective method for the drainage of walled-off pancreatic necrosis in various studies. However, complications such as bleeding, infection due to stent obstruction, stent migration, or buried stent syndrome have been reported. A preventive measure to minimize adverse events related to LAMS insertion by means of placing an anchoring DPS through the LAMS have been suggested but there has been no prospective randomized study to assess the utility of such measure to date. The study is to be conducted at a tertiary institution with an expertise in treating hepato-pancreato-biliary diseases. The main timeframe of the study is 3 weeks following LAMS insertion with or without DPS. All LAMS will be extracted 3 weeks after the initial procedure. The extraction will be preceded by a CT scan of the abdomen to assess whether the DPS needs to be left in place/ inserted in patients with incomplete resolution of the collection. In addition, material from the collection will be collected for cultivation at every endoscopic intervention to assess colonization by microbial flora over time. All patients will be closely followed with clinical, laboratory, and radiological assessment for 12 months in total. Our experience has shown failure of the (2.) method in 70 % of patients so far. Assuming a clinically significant difference to be a reduction to 40 % in failed patients using the (1) method, the required study population size was calculated to 62 patients (31 in both arms) by power analysis (at standard alpha and beta values). The final number was set to 70 as a safety measure.

Study Design
  • Study Type: Interventional
  • Estimated Enrollment: 70 participants
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Intervention Model Description: a prospective randomized cohort study
  • Masking: None (Open Label) ()
  • Primary Purpose: Treatment
  • Official Title: Endoscopic Ultrasound-guided Drainage Using Lumen-apposing Metal Stent With or Without Coaxial Plastic Stent for Treatment of Walled-off Pancreatic Necrosis: a Prospective Randomised Study
  • Actual Study Start Date: May 2019
  • Estimated Primary Completion Date: December 2021
  • Estimated Study Completion Date: May 2022
Arms and interventions
Arm Intervention/treatment
Experimental: LAMS plus DPS
Endoscopic ultrasound-guided (EUS) transmural drainage of walled-off pancreatic necrosis (WON) using lumen-apposing metal stent (LAMS) with coaxial double-pigtail plastic stent (DPS).
Procedure: EUS-guided drainage using LAMS with DPS
Endoscopic ultrasound-guided drainage using lumen-apposing metal stent with coaxial plastic stent in the treatment of walled-off pancreatic necrosis.
Active Comparator: LAMS alone
Endoscopic ultrasound-guided (EUS) transmural drainage of walled-off pancreatic necrosis (WON) using lumen-apposing metal stent (LAMS) alone.
Procedure: EUS-guided drainage using LAMS alone
Endoscopic ultrasound-guided drainage using lumen-apposing metal stent without coaxial plastic stent in the treatment of walled-off pancreatic necrosis.
Outcome Measures
  • Primary Outcome Measures: 1. Failure of method [ Time Frame: up to 1 month ]
    Defined as a necessity of re-intervention (endoscopic, surgical, percutaneous) within the period following LAMS insertion and before its planned extraction due to complications related to LAMS insertion and/or clinical deterioration.
  • 2. Mortality [ Time Frame: up to 12 months ]
    Overall mortality during subsequent follow-up
  • Secondary Outcome Measures: 1. Hospital stay [ Time Frame: up to 1 month ]
    Total length of hospital stay within the period following LAMS insertion until its extraction.
  • 2. Clinical success rate [ Time Frame: up to 1 month ]
    Resolution of the collection and symptoms following endoscopic drainage with LAMS before its extraction.
  • 3. Adverse events [ Time Frame: up to 1 month ]
    Primarily complications caused by LAMS itself (bleeding due to vessel erosion, secondary infection due to stent obstruction, stent migration, buried stent syndrome).
  • 4. Number of procedures [ Time Frame: up to 1 month ]
    Number of forced endoscopic interventions (direct endoscopic necrosectomy, debridement, desobliteration, etc.) required to achieve resolution.
  • 5. Recurrence rate [ Time Frame: up to 12 months ]
    Recurrence of the collection accompanied by symptoms provided there had been previous clinical success with documented resolution of the collection by radiological studies.
  • 6. Microbiological cultivation [ Time Frame: up to 1 month ]
    Material from the collection will be collected at every endoscopic intervention (at least during insertion and extraction of LAMS) to assess colonization by microbial flora over time.
Eligibility Criteria
  • Ages Eligible for Study: 18 Years and older (Adult, Older Adult)
  • Sexes Eligible for Study: All
  • Accepts Healthy Volunteers: No
Criteria

Inclusion Criteria:

- walled-off pancreatic necrosis (WON) indicated for endoscopical drainage

- signed informed consent form

Exclusion Criteria:

- patient disagreement with the study

- types of collections other than WON

- drainage with stents other than LAMS

- previous attempts at drainage of WON

- severe coagulopathy or thrombocytopenia

Contacts and Locations
Contacts

Contact: Petr Vanek, MD +420 58844 4803 petr.vanek3@fnol.cz

Contact: Premysl Falt, MD, Ph.D. premysl.falt@fnol.cz

Locations

Czechia
University Hospital Olomouc, Second Department of Internal Medicine - Gastroenterology and Geriatrics
Olomouc

Sponsors and Collaborators

Palacky University

Investigators

Principal Investigator: Petr Vanek, MD Assistant Professor, physician

More Information
  • Responsible Party: Palacky University
  • ClinicalTrials.gov Identifier: NCT03923686 History of Changes
  • Other Study ID Numbers: FNOL 2IK 001
  • First Posted: April 22, 2019 Key Record Dates
  • Last Update Posted: April 2, 2020
  • Last Verified: March 2020
  • Studies a U.S. FDA-regulated Drug Product: No
  • Studies a U.S. FDA-regulated Device Product: No
  • Keywords provided by Palacky University: Walled off necrosis
    Acute pancreatitis
    Necrotizing pancreatitis
    Endoscopic drainage
    Lumen apposing metal stents
    Double pigtail plastic stent
  • Additional relevant MeSH terms: Pancreatitis
    Pancreatitis, Acute Necrotizing
    Necrosis